SCHEMBL3725786

SCHEMBL3725786

Cc1cc(-c2cccc(OC(F)(F)F)c2)ccc1N

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.53
CYP3A4 P08684 1/20 0.53
TSHR P16473 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
DHODH Q02127 3/20 0.47
XDH P47989 1/20 0.46
KCNH2 Q12809 3/20 0.45
SCN10A Q9Y5Y9 1/20 0.45
PTGES2 Q9H7Z7 2/20 0.43
BACE1 P56817 4/20 0.43
ADORA2A P29274 1/20 0.42
ADORA1 P30542 1/20 0.42
CTSD P07339 2/20 0.42
BACE2 Q9Y5Z0 1/20 0.41
SLC13A5 Q86YT5 1/20 0.41
PRMT1 Q99873 1/20 0.41
FFAR1 O14842 1/20 0.40
FFAR4 Q5NUL3 1/20 0.40
GALR1 P47211 1/20 0.40
S1PR1 P21453 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2380991 0.85 XDH (0.49) TDP1DHODHXDHKCNH2SCN10A
SCHEMBL1337687 0.83 XDH (0.47) DHODHXDHKCNH2SCN10APTGES2
SCHEMBL29382481 0.81 CYP3A4 (0.45) ALDH1A1CYP3A4TSHRTDP1FFAR4
SCHEMBL1039855 0.81 CYP3A4 (0.45) ALDH1A1CYP3A4TSHRTDP1FFAR4
SCHEMBL24156278 0.81 ALDH1A1 (0.44) ALDH1A1PTGES2
SCHEMBL3728641 0.81 ALDH1A1 (0.52) ALDH1A1CYP3A4TSHRDHODHXDH
SCHEMBL1044062 0.80 CYP1A2 (0.51) DHODHXDHKCNH2SCN10APTGES2
SCHEMBL1337217 0.80 TAAR1 (0.52) CYP3A4TDP1DHODHXDHKCNH2
SCHEMBL5542229 0.78 PTGES2 (0.50) DHODHXDHKCNH2SCN10APTGES2
SCHEMBL21770975 0.78 XDH (0.51) ALDH1A1CYP3A4TSHRXDHKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8691852-B2 Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors AMIRALL, S.A. (ES) 2014-04-08 US disclosed
US-20120294854-A1 AMINO NICOTINIC AND ISONICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS LABORATORIOS ALMIRALL, S.A. 2012-11-22 US disclosed
US-8258308-B2 Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors LABORATORIOS ALMIRALL, S.A. (ES) 2012-09-04 US disclosed
EP-2121614-B1 AMINO NICOTINIC AND ISONICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS ALMIRALL SA (ES) 2012-06-20 EP disclosed
US-20100074898-A1 AMINO NICOTINIC AND ISONICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS LABORATORIOS ALMIRALL, S.A. (ES) 2010-03-25 US disclosed
EP-2121614-A1 AMINO NICOTINIC AND ISONICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS Almirall, S.A. (ES) 2009-11-25 EP disclosed
WO-2008077639-A1 AMINO NICOTINIC AND ISONICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS LABORATORIOS ALMIRALL, S.A. (ES) 2008-07-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100074898-A1 AMINO NICOTINIC AND ISONICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS DHODH, NQO2, DAO ALDH1A1 147/4885CYP3A4 2249/4885TSHR 3745/4885
US-20120294854-A1 AMINO NICOTINIC AND ISONICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS DHODH, NQO2, DAO ALDH1A1 147/4885CYP3A4 2249/4885TSHR 3745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.